PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, presenting promising advancements throughout several healthcare and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, additional reputable substitute for therapeutic use